TARA KENDALL: Open Payments
NPI 1164052742 · POCAHONTAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 25 payments from 12 companies in 2025. Trend: 2023 $787 · 2024 $486 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $143 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 4 | $37 |
| Lundbeck LLC | 1 | $28 |
| Amgen Inc. | 2 | $28 |
| ABBVIE INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, REXULTI, GEMTESA, Ozempic, VOQUEZNA, AIRSUPRA, OTEZLA, FARXIGA.
Industry payments across AR — which companies pay providers there.
